Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient

European Journal of Clinical Nutrition

Volumn 68, Issue 4, 2014, Pages 531-533

  Fierz, Y C ^a   Kenmeni, R ^a   Gonthier, A ^a   Lier, F ^a   Pralong, F ^a   Coti Bertrand, P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLECALCIFEROL; FERRIC CARBOXYMALTOSE; FERRITIN; PHOSPHATE; FERRIC ION; MALTOSE;

ADULT; ANOREXIA; ARTICLE; ASTHENIA; BODY MASS; BODY WEIGHT; BULIMIA; CASE REPORT; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; HYPOPHOSPHATEMIA; IRON DEFICIENCY; MALNUTRITION; MUSCLE WEAKNESS; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; SECONDARY OSTEOPOROSIS; WEIGHT REDUCTION; YOUNG ADULT; ANALOGS AND DERIVATIVES; ANEMIA, IRON-DEFICIENCY; CHEMICALLY INDUCED; COMPLICATION; DIET SUPPLEMENTATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PARENTERAL NUTRITION; PATHOLOGY;

ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; ANOREXIA; BULIMIA; DIETARY SUPPLEMENTS; FEMALE; FERRIC COMPOUNDS; HUMANS; HYPOPHOSPHATEMIA; INJECTIONS, INTRAVENOUS; MALNUTRITION; MALTOSE; PARENTERAL NUTRITION; PHOSPHATES; WEIGHT LOSS; YOUNG ADULT;

EID: 84897979053     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.20     Document Type: Article

References (10)

1. Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: A randomized, controlled trial. Transfusion 2009; 49: 2719-2728.
2. Hussain I, Bhoyroo J, Butcher A, Koch TA, He A, Bregman DB. Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia. Anemia 2013; 2013: 169107.
3. Wolf M, Koch TA, Bregman DB. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 2013; 28: 1793-1803.
4. Mani LY, Nseir G, Venetz JP, Pascual M. Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient. Transplantation 2010; 90: 804-805.
5. Subramanian R, Khardori R. Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment. Medicine (Baltimore) 2000; 79: 1-8.
6. Vaucher P, Druais PL, Waldvogel S, Favrat B. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: A randomized controlled trial. CMAJ 2012; 184: 1247-1254.
7. Schouten BJ, Hunt PJ, Livesey JH, Frampton CM, Soule SG. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: A prospective study. J Clin Endocrinol Metab 2009; 94: 2332-2337.
8. Hu MC, Shiizaki K, Kuro-o M, Moe OW. Fibroblast growth factor 23 and Klotho: Physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 2013; 75: 503-533.
9. Okada M, Imamura K, Iida M, Fuchigami T, Omae T. Hypophosphatemia induced by intravenous administration of saccharated iron oxide. Klin Wochenschr 1983; 61: 99-102.
10. Vadhan-Raj S, Strauss W, Ford D, Bernard K, Boccia R, Li J, Allen LF. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. Am J Hematol 2013; 89: 7-12.